Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$1.22 | -$1.22 | -$1.22 |
| Q2 2026 | 2 | -$1.14 | -$0.68 | -$0.92 |
| Q3 2026 | 3 | -$0.83 | -$0.51 | -$0.71 |
| Q4 2026 | 1 | -$0.78 | -$0.78 | -$0.78 |
| Q1 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2027 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q1 2028 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q2 2028 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2028 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2028 | 1 | -$0.05 | -$0.05 | -$0.05 |
Imunon Inc last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-0.84 earnings per share for the quarter, topping analysts' consensus estimates of $-1.215 by $0.375. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Imunon Inc has generated $-7 earnings per share over the last year ($-6.83 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Imunon Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | -$1.22 | -$0.84 | 0.38 | $0 | $0 |
| 03/31/2026 | Q4 2025 | -$1.43 | -$1.99 | -0.56 | $0 | $0 |
| 11/13/2025 | Q3 2025 | -$1.73 | -$1.16 | 0.57 | $0 | $0 |
| 08/05/2025 | Q2 2025 | -$3.09 | -$1.87 | 1.22 | N/A | $0 |
| 05/12/2025 | Q1 2025 | -$4.56 | -$3.68 | 0.88 | N/A | $0 |
| 02/27/2025 | Q4 2024 | -$0.36 | -$3.65 | -3.29 | $125.00 K | $0 |
| 11/07/2024 | Q3 2024 | -$0.37 | -$4.38 | -4.01 | $125.00 K | $0 |
| 08/14/2024 | Q2 2024 | -$0.55 | -$6.64 | -6.09 | $125.00 K | $0 |
| 05/13/2024 | Q1 2024 | -$0.57 | -$6.84 | -6.27 | N/A | $0 |
| 03/28/2024 | Q4 2023 | -$0.59 | -$6.78 | -6.19 | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$4.84 | N/A | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.71 | -$7.94 | -7.23 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.69 | -$8.81 | -8.12 | N/A | $0 |
| 03/30/2023 | Q4 2022 | -$0.80 | -$23.21 | -22.41 | N/A | $125.00 K |
| 11/14/2022 | Q3 2022 | -$0.81 | -$11.30 | -10.49 | N/A | $125.00 K |
| 06/30/2022 | Q2 2022 | N/A | -$11.29 | N/A | N/A | $125.00 K |
| 03/31/2022 | Q1 2022 | -$0.90 | -$23.68 | -22.78 | N/A | $125.00 K |
| 12/31/2021 | Q4 2021 | N/A | -$9.54 | N/A | N/A | $125.00 K |
| 09/30/2021 | Q3 2021 | N/A | -$12.23 | N/A | N/A | $125.00 K |
| 06/30/2021 | Q2 2021 | N/A | -$12.41 | N/A | N/A | $125.00 K |
In the previous quarter, Imunon Inc (:IMNN) reported $-0.84 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.215 by $0.375.
The conference call for Imunon Inc's latest earnings report can be listened to online.
The conference call transcript for Imunon Inc's latest earnings report can be read online.
Imunon Inc (:IMNN) has a recorded net income of $-14,495,000.Imunon Inc has generated $-6.83 earnings per share over the last four quarters.
Imunon Inc (:IMNN) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED